Skip to main content
. 2022 Aug 22;14(16):4042. doi: 10.3390/cancers14164042

Figure 6.

Figure 6

In vivo long-term efficacy of NIR-PIT with Cet-IR700 in mEERL-hEGFR tumors: (A) tumor volume curve (n = 10; one-way ANOVA followed by Tukey’s test; ***, p < 0.001 and ****, p < 0.0001; ns: not significant); (B) Kaplan–Meier survival curve (n = 10; log-rank test with Bonferroni correction; **, p < 0.01 and ****, p < 0.0001; N.S.: not significant).